A bipartisan effort in the U.S. Senate seeks to improve the safety of infant formula. Introduced by Sen. John Hoeven, R-ND, and Sen. Gary Peters, D-MI, ...
LANSING, Mich. — Sen. Gary Peters has reintroduced a bill designed to stop future infant formula shortages from happening. The bipartisan legislation was drafted after a nationwide shortage in 2022 ...
United States Sen. Gary Peters has reintroduced bipartisan legislation to help prevent future infant formula shortages.
Michigan Senator Gary Peters reintroduced legislation to help prevent future shortages and contaminations. The contaminated formula led to the deaths of nine babies and a nationwide shortage. Peters’ ...
Abbott initiated a recall as part of a larger voluntary action covering Similac, Alimentum, and EleCare. The dominant player in the U.S. infant formula market, Abbott controls about 40% of the market ...
Labeled similarly to FDA-regulated infant formulas and sold on the same store shelves, Abbott's "Go & Grow Toddler Drink by Similac" and "Pure Bliss Toddler Drink by Similac" are labeled "Stage 3 ...
The lawsuit accuses Abbott of creating products called “transition formulas,” “follow-on formulas,” “weaning formulas” and “toddler milks” to boost earnings as infant formula sales ...
An outbreak of the potentially deadly bacteria Cronobacter sakazaaki at major infant formula supplier Abbott’s factory in Michigan prompted its closure for several months and a mass product recall.
In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks on Jim Cramer's radar. Jim Cramer, host of Mad Money, recently emphasized the ...
I think Abbott will win these baby formula cases. Yet, who wants that overhang, right? Certainly not Wall Street. So what does this stock do? It languishes. Who knows how quickly things can change ...
Danielle and Andrew West spent their first month as parents praying their child would live. Their son Owen, born six weeks early in November 2015, developed necrotizing enterocolitis a few days ...
I think Abbott will win these baby formula cases. Yet, who wants that overhang, right? Certainly not Wall Street. So what does this stock do? It languishes. Who knows how quickly things can change ...